Avexitide for low blood sugar after weight-loss surgery
Part of Hormones & metabolism clinical trials.
This program provides access to an investigational drug called avexitide for people who have low blood sugar after weight-loss surgery (post-bariatric hypoglycemia). It may help manage symptoms when other treatments haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had weight-loss surgery (Roux-en-Y gastric bypass) at least 12 months ago.
- You have been diagnosed with low blood sugar after this surgery.
- You cannot get avexitide through a clinical trial and have no other good treatment options.
- You are not taking certain diabetes medications (GLP-1 receptor agonists) or have not taken other investigational drugs recently.
- You do not have severe liver or kidney problems, pancreatitis, or other conditions that make treatment unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different ways to manage episodes of low blood sugar that can happen after meals in people who have had weight-loss or other stomach surgery. It looks at whether changes in diet, certain medications, or a procedure done with a scope can help prevent these episodes.
This study looks at how food moves through the body and how that may affect episodes of low blood sugar caused by too much insulin. It may help researchers better understand and possibly improve care for people who get hypoglycemia, especially after bariatric (weight-loss) surgery.
This trial tests a medication called mizagliflozin to see if it can reduce episodes of low blood sugar in people who have had gastric bypass surgery. If you experience symptoms like confusion or fainting when your blood sugar drops, this study might help.
This trial tests whether a diabetes medication called dapagliflozin helps smooth out blood sugar swings after bariatric (weight-loss) surgery. It may help people with type 2 diabetes achieve better control after their surgery.
This trial tests whether canakinumab can reduce frequent low blood sugar episodes after bariatric (weight-loss) surgery. It is designed for people who keep having low blood sugar despite dietary changes.
This early trial studies how blood sugar moves in people after certain weight-loss surgery compared with people without surgery. It may help researchers understand why blood sugar can drop too low and how treatments like atropine affect that process.
Hear when a new Post-bariatric Hypoglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.